The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes

Abroad (travel likely)Recruiting

Conditions

Dry Eye Disease (DED)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

School of Optometry and Vision Science, Sydney, New South Wales, Australia
Contact: Study coordinator (Lisa Professor, PhD) · l.keay@unsw.edu.au · +61 02 9385 4624

Study leads

Fiona Stapleton Professor, PhD
Principal Investigator
The University of New South Wales

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE2, PHASE3

Aliso Viejo, United States · Garden Grove, United States

Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease

Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea

Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease

Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE4

Andover, United States

An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease

Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE2

Chandler, United States · Azusa, United States